Summit Therapeutics
SMMT
#2244
Rank
HK$62.37 B
Marketcap
HK$77.99
Share price
-5.87%
Change (1 day)
-38.10%
Change (1 year)

Market capitalization of Summit Therapeutics (SMMT)

Market cap: HK$62.37 Billion

As of November 2026 Summit Therapeutics has a market cap of HK$62.37 Billion. This makes Summit Therapeutics the world's 2244th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Summit Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$62.37 B-40.63%
2025HK$105.07 B0.78%
2024HK$104.25 B629.77%
2023HK$14.28 B113.7%
2022HK$6.68 B226.17%
2021HK$2.04 B-31.62%
2020HK$2.99 B258.04%
2019HK$0.83 B464.97%
2018HK$0.14 B-88.53%
2017HK$1.29 B58.3%
2016HK$0.81 B-25.29%
2015HK$1.09 B

End of Day market cap according to different sources

On Nov 21st, 2026 the market cap of Summit Therapeutics was reported to be:

HK$62.37 Billion
by Nasdaq info icon info icon
HK$62.37 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
HK$11.20 B-82.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
HK$1.75 B-97.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
HK$0.44 B-99.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
HK$48.32 B-22.52%๐Ÿ‡บ๐Ÿ‡ธ USA